Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1119782
Abstract: Introduction Diabetic sarcopenia (DS) is characterized by muscle atrophy, slower nerve conduction, reduced maximum tension generated by skeletal muscle contraction, and slower contraction rate. Hence, DS can cause limb movement degeneration, slow movement, reduced balance,… read more here.
Keywords: patients diabetic; diabetic sarcopenia; analysis; biomarkers patients ... See more keywords